scPharmaceuticals Reports Variability in Shelf-Life Testing for SCP-111 Combination Product
On December 11, 2024, scPharmaceuticals Inc. shared in an 8-K filing that it has encountered variability in shelf-life testing within one lot of the SCP-111 Combination Product. While the potential impact on the Company’s planned submission of the sNDA in January 2025 remains uncertain currently, there is a possibility that the submission might be delayed […]
More Stories
Trust Point Inc. Cuts Position in The Boeing Company (NYSE:BA)
Trust Point Inc. decreased its position in The Boeing Company (NYSE:BA – Free Report) by 15.4% during the first quarter,...
Prime Day Just Got Even Better With Amazon’s Exciting Free Game Offers
Ahead of the long-awaited Prime Day 2025, Amazon has already started offering a surprise to its Prime Members – free...
Exchange Traded Concepts LLC Reduces Position in Merck & Co., Inc. (NYSE:MRK)
Exchange Traded Concepts LLC decreased its stake in shares of Merck & Co., Inc. (NYSE:MRK – Free Report) by 74.8%...
Capital One Shopping Review: Save More While You Shop Online
In this digital shopping era, getting your hands on the best deals can be a little time-consuming, but not for...
Top Electric Vehicle Stocks To Follow Today – June 15th
Tesla, Shell, Rivian Automotive, Navitas Semiconductor, and Enphase Energy are the five Electric Vehicle stocks to watch today, according to...
Vanguard Dividend Appreciation ETF (NYSEARCA:VIG) Shares Sold by Cyndeo Wealth Partners LLC
Cyndeo Wealth Partners LLC lessened its stake in Vanguard Dividend Appreciation ETF (NYSEARCA:VIG – Free Report) by 13.2% during the...